Skip to main content
. 2021 Mar 23;8:20499361211004367. doi: 10.1177/20499361211004367

Table 1.

Patient clinical characteristics for cases and controls.

Patient characteristics—n (%), mean ± SD N Controls
n = 125*
Pulmonary cryptococcosis cases
n = 35*
p-value
Demographics
 Gender, male 221 106 (84.8%) 27 (77.1%) 0.285
 Age, years 221 53.6 ± 14.9 59.5 ± 14.5 0.038
 Race, White 126 73 (63.5%) 22 (64.7%) 0.242
 BMI, kg/m2 147 25.3 ± 5.9 24.9 ± 4.7 0.757
Risk factors
 Smoking, current 111 30 (24.4%) 4 (11.4%) 0.223
 Transplant 219 28 (22.4%) 9 (26.5%) 0.618
 Diabetes mellitus 221 25 (20%) 9 (25.7%) 0.465
 Uncontrolled diabetes mellitus 211 9 (7.6%) 6 (17.1%) 0.093
 HIV 220 46 (36.8%) 6 (17.7%) 0.035
 Malignancy 220 31 (24.8%) 12 (35.3%) 0.222
 Cirrhosis 221 6 (4.8%) 1 (2.9%) 0.619
 Steroids 217 27 (21.8%) 9 (27.3%) 0.504
Symptoms at presentation
 Headaches 219 33 (26.6%) 2 (5.9%) 0.010
 Altered mental status 221 48 (38.4%) 4 (11.4%) 0.003
 Respiratory 220 32 (25.8%) 28 (80%) <0.001
Labs
 Hemoglobin, g/dL 215 12.3 ± 2.6 11.9 ± 2.9 0.513
 Platelets, 109/L 214 207.9 ± 135.2 207.7 ± 84 0.992
 Creatinine, mg/dl 208 1.3 ± 1.2 1.3 ± 0.8 0.843
 CD4 count, cells/µL 86 206 ± 224.9 200.9 ± 319.1 0.952
 HbA1c, % 96 6.24 ± 1.8 6.8 ± 1.7 0.252
Outcome
 ICU stay 53 27 (36%) 7 (30.4%) 0.624
 Overall death 221 49 (39.2%) 15 (42.9%) 0.696
 Death within 10 weeks 221 12 (9.6%) 5 (14.3%) 0.427
 Death within 1 year 221 28 (22.4%) 8 (22.9%) 0.954

BMI, body mass index; HbA1c, hemoglobin A1c; ICU, intensive care unit.

*

some percentages were calculated on a different number due to missing values.